Abstract
The symptoms of Chlamydia pneumoniae infection are mostly derived from case reports and descriptions of outbreaks in which the diagnosis of infection has been made from the results of serological tests showing either high or rising titers of antibody to C. pneumoniae, suggesting that the patients had suffered from an acute or an asymptomatic form of respiratory infection. The micro-immunofluorescence test showing IgM and IgG antibodies is considered the golden standard in the serology of these infections. A fourfold rise in IgM antibody titers or a single titer of 1:16 or greater are considered evidence of recent infection as it is a single IgG titer > 1:512. If the IgM antibody titer is negative and the IgG titer is between 1:16 and 1:512 it is generally supposed that the patient has had an infection with C. pneumoniae in the past [3]. If the relatively insensitive complement fixation test (CFT) technique has been used with the non-specific genus antigen then an infection is assumed if there is a fourfold rise in serum antibody titer in the course of a period of 10 days to 4 weeks, and certainly if the CFT titer is greater than 1:64 Sometimes the patients fail completely to mount any form of complement fixing antibody response [8].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aldous MB, Grayston JT, Wang SP, Foy 14M (1992) Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle Families, 1966–1979. J Infect Dis 166: 646–649
Atmar RL, Greenberg SB (1989) Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent. Semin Respir Infect 4: 19–31
Beaty CD, Grayston JT, Wang SP et al (1991) Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 144: 1408–1410
Berdal BP, Fields PI, Mitchell SH, Hoddevik G (1990) Isolation of Chlamydia pneumoniae during an adenovirus outbreak In: Chlamydia infections. Bowie WR et al (eds), Cambridge University Press, Cambridge pp 445–448
Berdal BP, Scheel O, Ogaard AR, Hoel T, Gutteberg TJ, Anestad G (1992) Spread of subclinical Chlamydia pneumoniae infection in a closed community. Scand J Infect Dis 24: 431–436
Blasi F, Cosentini R, Denti F, Allegra L (1994) Chlamydia pneumoniae infection in two unrelated families. Eur Respir J 7: 102–4
Blasi F, Legnani D, Lombardo VM, Negretto GG, Magliano E, Pozzoli R, Chiodo F, Fasoli A, Allegra L (1993) Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 6: 19–22
Bourke SJ (1993) Chlamydial respiratory infections: common but difficult to diagnose. BMJ 306: 1219–1220
Erntell M, Ljunggren K, Gadd T, Persson K (1989) Erythema nodosum–a manifestation of Chlamydia pneumoniae (strain TWAR) infection. Scand J Infect Dis 21: 693–696
Grayston JT, Kuo CC, Wang SP, Altman J (1986) A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 315: 161–168
Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH (1990) A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161: 618–625
Grayston JT (1993) Chlamydia in atherosclerosis. Circulation 87: 1408–1409
Haidl S, Ivarsson S, Bjerre I, Persson K (1992) Guillain Barré Syndrome after Chlamydia pneumoniae infection. N Engl J Med 326: 576–577
Hahn DL (1993) Another possible risk factor for airway disease. Chest 104: 649
Hammerschlag MR, Qumei KK, Roblin PM (1992) In vitro activities of azithromycin, clarithromycin, L-ofloxacin and other antibiotics against Chlamydia pneumoniae. Antimicrob Agents Chemother 36: 1573–1574
Kleemola M, Saikku P, Viasakorpi R, Wang SP, Grayston JT (1988) Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland J Infect Dis 157: 230–236
Komaroff AL, Wang SP, Lee J, Grayston JT (1992) No association of chronic Chlamydia pneumoniae infection with chronic fatigue syndrome. J Infect Dis 165: 184
Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P (1993) Chlamydia pneumoniae specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 87: 1130–1134
Manie TJ, Harczy M, Mann 0E, Landymore RW, Raza A, Wang SP, Grayston JT (1990) Culture-negative endocarditis probably due to Chlamydia pneumoniae. J Infect Dis 161: 127–129
Marrie TJ, Grayston JT, Wang SP, Kuo CC (1987) Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med 106: 5007–5011
Marrie TJ (1993) Chlamydia pneumoniae. Thorax 48: 1–4
Maesen FPV, Davies BI, Costongs MAL (1992) Are high serum titres against Chlamydia pneumoniae significant in patients with community-acquired pneumonia? Eur Respir J [Suppl 151: 343
Mordhorst CH, Wang SP, Grayston JT (1992) Outbreak of Chlamydia pneumoniae infection in four farm families. Eur J Clin Microbiol Infect Dis 11: 617–620
Rumbak MJ, Baselski V, Belenchia JM, Griffin JP (1993) Case report: acute postoperative respiratory failure caused by Chlamydia pneumoniae and diagnosed by bronchoalveolar lavage. Am J Med Sci 6: 390–393
Saikku P, Wang SP, Kleemola M, Brander E, Rusanen E, Grayston JT (1985) An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 151: 832–839
Saikku P, Mattila K, Nieminen MS, Huttunen JK, Leinonen M, Ekman MR, Makela PH, Valtona V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii: 983–985
Saikku P, Ruutu P, Leinonen M, Panelius J, Tupasi TE, Grayston JT (1988) Acute lower respiratory tract infection associated with Chlamydial TWAR antibody in filipino children. J Infect Dis 158: 1095–1097
Shor A, Kuo CC, Patton DL (1992) Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82: 158–161
Stolk-Engelaar MVM, Peeters MF (1990) Heeft Chlamydia TWAR betekenis in Nederland ? Ned Tijdschr Geneeskd 134: 1094–1097
Sundelöf B, Gnarpe H, Gnarpe J (1993) An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum. Scand J Infect Dis 25: 259–261
Thom DH, Grayston JT (1991) Infections with Chlamydia pneumoniae strain TWAR. Clin Chest Med 12: 245–256
Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR (1992) Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268: 68–72
Torres A, El-Ebiary M (1993) Relevance of Chlamydia pneumoniae in community-acquired respiratory infections. Eur Respir J 6: 7–8
Van den Abeele AM, Van Renterghem L, Willems K, Plum J (1992) Prevalence of antibodies to Chlamydia pneumoniae in a Belgian population. J Infect 25 [Suppl 11: 87–90
Wesslen L, Pahlson C, Friman G, Fohlman J, Lindquist O, Johansson C (1992) Myocarditis caused by Chlamydia pneumoniae ( TWAR) and sudden unexpected death in a Swedish elite orienteer. Lancet 340: 427–428
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Italia, Milano
About this chapter
Cite this chapter
Maesen, F.P.V., Davies, B.I. (1995). Clinical Characteristics of Chlamydia pneumoniae Infection. In: Allegra, L., Blasi, F. (eds) Chlamydia Pneumoniae Infection. Springer, Milano. https://doi.org/10.1007/978-88-470-2201-0_6
Download citation
DOI: https://doi.org/10.1007/978-88-470-2201-0_6
Publisher Name: Springer, Milano
Print ISBN: 978-3-540-75007-9
Online ISBN: 978-88-470-2201-0
eBook Packages: Springer Book Archive